ACET Q4 2020 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+174.8% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$9M-172.8% margin

Net Income

-$9M-165.6% margin

EPS (Diluted)

$-7.36

QoQ Revenue Growth

+78.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$154M

Total Liabilities

$44M

Stockholders' Equity

$110M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+174.8%
Gross Profit	$5M	-$222M	+102.4%
Operating Income	-$9M	-$7M	-30.3%
Net Income	-$9M	-$7M	-36.2%